Ocular surface inflammation is regulated by innate immunity

Progress in Retinal and Eye Research

Volumn 31, Issue 6, 2012, Pages 551-575

  Ueta, Mayumi ^a,b   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

Epithelium; Inflammation; Innate immunity; Ocular surface; Toll like receptor

Indexed keywords

I KAPPA B KINASE EPSILON; NUCLEAR PROTEIN; PROTEIN EP3; PROTEIN MDA 5; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; BACTERIAL VIRULENCE; COMMENSALISM; EYE INFLAMMATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS EPIDERMIDIS; STEVENS JOHNSON SYNDROME;

EPITHELIUM; EYE DISEASES; HUMANS; IMMUNITY, INNATE;

EID: 84867400610     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.05.003     Document Type: Review

References (127)

1. Abe R., Shimizu T., Shibaki A., Nakamura H., Watanabe H., Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. American Journal of Pathology 2003, 162:1515-1520.
2. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
3. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schroder W., Roujeau J.C. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Archives of Dermatology 2002, 138:1019-1024.
4. Baum J.L. Current concepts in ophthalmology. Ocular infections. The New England Journal of Medicine 1978, 299:28-31.
5. Beauchamp G.R., Gillette T.E., Friendly D.S. Phlyctenular keratoconjunctivitis. Journal of Pediatric Ophthalmology and Strabismus 1981, 18:22-28.
6. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature Reviews Immunology 2003, 3:521-533.
7. Broide D.H. The pathophysiology of allergic rhinoconjunctivitis. Allergy and Asthma Proceedings: the Official Journal of Regional and State Allergy Societies 2007, 28:398-403.
8. Bullens D.M., Decraene A., Dilissen E., Meyts I., De Boeck K., Dupont L.J., Ceuppens J.L. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clinical and Experimental Allergy 2008, 38:1459-1467.
9. Cavassani K.A., Ishii M., Wen H., Schaller M.A., Lincoln P.M., Lukacs N.W., Hogaboam C.M., Kunkel S.L. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. The Journal of Experimental Medicine 2008, 205:2609-2621.
10. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nature Reviews Immunology 2008, 8:458-466.
11. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., Wu J.Y., Chen Y.T. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004, 428:486.
12. Cordell H.J. Detecting gene-gene interactions that underlie human diseases. Nature Reviews Genetics 2009, 10:392-404.
13. Correia O., Delgado L., Roujeau J.C., Le Cleach L., Fleming-Torrinha J.A. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples. Archives of Dermatology 2002, 138:29-32.
14. Doyle A., Beigi B., Early A., Blake A., Eustace P., Hone R. Adherence of bacteria to intraocular lenses: a prospective study. The British Journal of Ophthalmology 1995, 79:347-349.
15. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. Journal of Leukocyte Biology 1997, 61:246-257.
16. Ficker L., Seal D., Wright P. Staphylococcal infection and the limbus: study of the cell-mediated immune response. Eye (Lond) 1989, 3:190-193.
17. Forman R., Koren G., Shear N.H. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Safety 2002, 25:965-972.
18. Fukuda K., Kumagai N., Fujitsu Y., Nishida T. Fibroblasts as local immune modulators in ocular allergic disease. Allergology International 2006, 55:121-129.
19. Fukushima A. Roles of T-cells in the development of allergic conjunctival diseases. Cornea 2007, 26:S36-S40.
20. Graziano F.M., Stahl J.L., Cook E.B., Barney N.P. Conjunctival mast cells in ocular allergic disease. Allergy Asthma Proc 2001, 22:121-126.
21. Gros E., Bussmann C., Bieber T., Forster I., Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. The Journal of Allergy and Clinical Immunology 2009.
22. Hallen L.C., Burki Y., Ebeling M., Broger C., Siegrist F., Oroszlan-Szovik K., Bohrmann B., Certa U., Foser S. Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J Interferon Cytokine Res 2007, 27:675-680.
23. Hara J., Yasuda F., Higashitsutsumi M. Preoperative disinfection of the conjunctival sac in cataract surgery. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift fur Augenheilkunde 1997, 211(Suppl. 1):62-67.
24. Haynes R.J., Tighe P.J., Dua H.S. Antimicrobial defensin peptides of the human ocular surface. The British Journal of Ophthalmology 1999, 83:737-741.
25. Heinzmann A., Mao X.Q., Akaiwa M., Kreomer R.T., Gao P.S., Ohshima K., Umeshita R., Abe Y., Braun S., Yamashita T., Roberts M.H., Sugimoto R., Arima K., Arinobu Y., Yu B., Kruse S., Enomoto T., Dake Y., Kawai M., Shimazu S., Sasaki S., Adra C.N., Kitaichi M., Inoue H., Yamauchi K., Tomichi N., Kurimoto F., Hamasaki N., Hopkin J.M., Izuhara K., Shirakawa T., Deichmann K.A. Genetic variants of IL-13 signalling and human asthma and atopy. Human Molecular Genetics 2000, 9:549-559.
26. Hingorani M., Calder V.L., Buckley R.J., Lightman S.L. The role of conjunctival epithelial cells in chronic ocular allergic disease. Experimental Eye Research 1998, 67:491-500.
27. Honda T., Matsuoka T., Ueta M., Kabashima K., Miyachi Y., Narumiya S. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. The Journal of Allergy and Clinical Immunology 2009, 124:809-818. e802.
28. Horisberger M.A. Interferons, Mx genes, and resistance to influenza virus. American Journal of Respiratory and Critical Care Medicine 1995, 152:S67-S71.
29. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. The Journal of Immunology 2002, 168:4531-4537.
30. Hozono Y., Ueta M., Hamuro J., Kojima K., Kawasaki S., Yamazaki K., Kinoshita S. Human corneal epithelial cells respond to ocular-pathogenic, but not to nonpathogenic-flagellin. Biochemical and Biophysical Research Communications 2006, 347:238-247.
31. Hung S.I., Chung W.H., Liou L.B., Chu C.C., Lin M., Huang H.P., Lin Y.L., Lan J.L., Yang L.C., Hong H.S., Chen M.J., Lai P.C., Wu M.S., Chu C.Y., Wang K.H., Chen C.H., Fann C.S., Wu J.Y., Chen Y.T. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:4134-4139.
32. Jin H.K., Yoshimatsu K., Takada A., Ogino M., Asano A., Arikawa J., Watanabe T. Mouse Mx2 protein inhibits hantavirus but not influenza virus replication. Archives of Virology 2001, 146:41-49.
33. Johnson A.C., Heinzel F.P., Diaconu E., Sun Y., Hise A.G., Golenbock D., Lass J.H., Pearlman E. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Investigative Ophthalmology & Visual Science 2005, 46:589-595.
34. Kaniwa N., Saito Y., Aihara M., Matsunaga K., Tohkin M., Kurose K., Sawada J., Furuya H., Takahashi Y., Muramatsu M., Kinoshita S., Abe M., Ikeda H., Kashiwagi M., Song Y., Ueta M., Sotozono C., Ikezawa Z., Hasegawa R. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008, 9:1617-1622.
35. Kato A., Favoreto S., Avila P.C., Schleimer R.P. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. The Journal of Immunology 2007, 179:1080-1087.
36. Kawai T., Akira S. TLR signaling. Seminars in Immunology 2007, 19:24-32.
37. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. International Immunology 2009, 21:317-337.
38. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology 2005, 6:981-988.
39. Kinoshita H., Takai T., Le T.A., Kamijo S., Wang X.L., Ushio H., Hara M., Kawasaki J., Vu A.T., Ogawa T., Gunawan H., Ikeda S., Okumura K., Ogawa H. Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. The Journal of Allergy and Clinical Immunology 2008.
40. Kloos W.E., Musselwhite M.S. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Applied Microbiology 1975, 30:381-385.
41. Klunker S., Trautmann A., Akdis M., Verhagen J., Schmid-Grendelmeier P., Blaser K., Akdis C.A. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. The Journal of Immunology 2003, 171:1078-1084.
42. Kojima K., Ueta M., Hamuro J., Hozono Y., Kawasaki S., Yokoi N., Kinoshita S. Human conjunctival epithelial cells express functional Toll-like receptor 5. The British Journal of Ophthalmology 2008, 92:411-416.
43. Kumar A., Zhang J., Yu F.S. Toll-like receptor 3 agonist poly(I: C)-induced antiviral response in human corneal epithelial cells. Immunology 2006, 117:11-21.
44. Kumar A., Yin J., Zhang J., Yu F.S. Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Investigative Ophthalmology & Visual Science 2007, 48:4664-4670.
45. Kunikata T., Yamane H., Segi E., Matsuoka T., Sugimoto Y., Tanaka S., Tanaka H., Nagai H., Ichikawa A., Narumiya S. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nature Immunology 2005, 6:524-531.
46. Leaute-Labreze C., Lamireau T., Chawki D., Maleville J., Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Archives of Disease in Childhood 2000, 83:347-352.
47. Levi N., Bastuji-Garin S., Mockenhaupt M., Roujeau J.C., Flahault A., Kelly J.P., Martin E., Kaufman D.W., Maison P. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 2009, 123:e297-304.
48. Lonjou C., Thomas L., Borot N., Ledger N., de Toma C., LeLouet H., Graf E., Schumacher M., Hovnanian A., Mockenhaupt M., Roujeau J.C. A marker for Stevens-Johnson syndrome: ethnicity matters. The Pharmacogenomics Journal 2006, 6:265-268.
49. Lonjou C., Borot N., Sekula P., Ledger N., Thomas L., Halevy S., Naldi L., Bouwes-Bavinck J.N., Sidoroff A., de Toma C., Schumacher M., Roujeau J.C., Hovnanian A., Mockenhaupt M. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008, 18:99-107.
50. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
51. Miyairi I., Tatireddigari V.R., Mahdi O.S., Rose L.A., Belland R.J., Lu L., Williams R.W., Byrne G.I. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. The Journal of Immunology 2007, 179:1814-1824.
52. Mockenhaupt M., Viboud C., Dunant A., Naldi L., Halevy S., Bouwes Bavinck J.N., Sidoroff A., Schneck J., Roujeau J.C., Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. The Journal of Investigative Dermatology 2008, 128:35-44.
53. Mondini M., Costa S., Sponza S., Gugliesi F., Gariglio M., Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity 2010, 43:226-231.
54. Mondino B.J., Kowalski R. Phlyctenulae and catarrhal infiltrates-occurrence in rabbits immunised with staphylococcal cell walls. Archives of Ophthalmology 1982, 100:1968-1971.
55. Mondino B.J., Brown S.I., Rabin B.S. Role of complement in corneal inflammation. Transactions of the Ophthalmological Societies of the United Kingdom 1978, 98:363-366.
56. Mondino B.J., Kowalski R., Ratajczak H.V., Petes J., Cutler S.B., Bronw S.I. Rabbit model of phlyctenulosis and catarrhal infiltrates. Archives of Ophthalmology 1981, 99:891-895.
57. Mondino B.J., Brown S.I., Biglan A.W. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Archives of Ophthalmology 1982, 100:1453-1454.
58. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
59. Neiberg M.N., Sowka J. Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea. Optometry 2008, 79:133-137.
60. Ohji M., Ohmi G., Kiritoshi A., Kinoshita S. Goblet cell density in thermal and chemical injuries. Archives of Ophthalmology 1987, 105:1686-1688.
61. Ono S.J., Abelson M.B. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. The Journal of Allergy and Clinical Immunology 2005, 115:118-122.
62. Peebles R.S. Viral infections, atopy, and asthma: is there a causal relationship?. The Journal of Allergy and Clinical Immunology 2004, 113:S15-S18.
63. Pinna A., Zanetti S., Sotgiu M., Sechi L.A., Fadda G., Carta F. Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. The British Journal of Ophthalmology 1999, 83:771-773.
64. Power W.J., Ghoraishi M., Merayo-Lloves J., Neves R.A., Foster C.S. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995, 102:1669-1676.
65. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005, 79:12893-12904.
66. Redfern R.L., Reins R.Y., McDermott A.M. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Experimental Eye Research 2011, 92:209-220.
67. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69:138-147.
68. Roujeau J.C., Bracq C., Huyn N.T., Chaussalet E., Raffin C., Duedari N. HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens 1986, 28:251-254.
69. Roujeau J.C., Kelly J.P., Naldi L., Rzany B., Stern R.S., Anderson T., Auquier A., Bastuji-Garin S., Correia O., Locati F., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. The New England Journal of Medicine 1995, 333:1600-1607.
70. Saito H., Kubota M., Roberts R.W., Chi Q., Matsunami H. RTP family members induce functional expression of mammalian odorant receptors. Cell 2004, 119:679-691.
71. Seal D.V., McGill J.I., Jacobs P., Liakos G.M., Goulding N.J. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. The British Journal of Ophthalmology 1985, 69:604-611.
72. Shaveta G., Shi J., Chow V.T., Song J. Structural characterization reveals that viperin is a radical S-adenosyl-L-methionine (SAM) enzyme. Biochemical and Biophysical Research Communications 2010, 391:1390-1395.
73. Smolin G., Okumoto M. Staphylococcal blepharitis. Archives of Ophthalmology 1977, 95:812-816.
74. Sotozono C., Inagaki K., Fujita A., Koizumi N., Sano Y., Inatomi T., Kinoshita S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea 2002, 21:S94-101.
75. Sotozono C., Ang L.P., Koizumi N., Higashihara H., Ueta M., Inatomi T., Yokoi N., Kaido M., Dogru M., Shimazaki J., Tsubota K., Yamada M., Kinoshita S. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology 2007, 114:1294-1302.
76. Sotozono C., Ueta M., Kinoshita S. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis. Archives of Dermatology 2009, 145:1336-1337. author reply 1337-1338.
77. Sotozono C., Ueta M., Koizumi N., Inatomi T., Shirakata Y., Ikezawa Z., Hashimoto K., Kinoshita S. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 2009, 116:685-690.
78. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., Smith K., Gorman D., Zurawski S., Abrams J., Menon S., McClanahan T., de Waal-Malefyt Rd R., Bazan F., Kastelein R.A., Liu Y.J. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunology 2002, 3:673-680.
79. Stevens A.M., Johnson F.C. A new eruptive fever associated with stomatitis and opthalmia: report of two cases in children. American Journal of Diseases of Children 1922, 24:526-533.
80. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nature Reviews Immunology 2003, 3:879-889.
81. Strober W. Epithelial cells pay a Toll for protection. Nature Medicine 2004, 10:898-900.
82. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annual Review of Immunology 2002, 20:495-549.
83. Suzuki T., Mitsuishi Y., Sano Y., Yokoi N., Kinoshita S. Phlyctenular keratitis associated with meibomitis in young patients. American Journal of Ophthalmology 2005, 140:77-82.
84. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995, 33:2233-2239.
85. Thygeson P. Complications of staphylococcic blepharitis. American Journal of Ophthalmology 1969, 68:446-449.
86. Tokunaga K., Ishikawa Y., Ogawa A., Wang H., Mitsunaga S., Moriyama S., Lin L., Bannai M., Watanabe Y., Kashiwase K., Tanaka H., Akaza T., Tadokoro K., Juji T. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997, 46:199-205.
87. Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea 2008, 27:S31-S40.
88. Ueta M. Regulation of ocular surface inflammation by prostaglandin E receptor subtype EP3. Cornea 2010, 29:S57-S61.
89. Ueta M., Kinoshita S. Innate immunity of the ocular surface. Brain Research Bulletin 2010, 81:219-228.
90. Ueta M., Kinoshita S. Ocular surface inflammation mediated by innate immunity. Eye & Contact Lens 2010, 36:269-281.
91. Ueta M., Nochi T., Jang M.H., Park E.J., Igarashi O., Hino A., Kawasaki S., Shikina T., Hiroi T., Kinoshita S., Kiyono H. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. The Journal of Immunology 2004, 173:3337-3347.
92. Ueta M., Hamuro J., Kiyono H., Kinoshita S. Triggering of TLR3 by polyI: C in human corneal epithelial cells to induce inflammatory cytokines. Biochemical and Biophysical Research Communications 2005, 331:285-294.
93. Ueta M., Hamuro J., Yamamoto M., Kaseda K., Akira S., Kinoshita S. Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Investigative Ophthalmology & Visual Science 2005, 46:579-588.
94. Ueta M., Iida T., Sakamoto M., Sotozono C., Takahashi J., Kojima K., Okada K., Chen X., Kinoshita S., Honda T. Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface. Journal of Medical Microbiology 2007, 56:77-82.
95. Ueta M., Nakamura T., Tanaka S., Kojima K., Kinoshita S. Development of eosinophilic conjunctival inflammation at late-phase reaction in mast cell-deficient mice. The Journal of Allergy and Clinical Immunology 2007, 120:476-478.
96. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., Kinoshita S. Association of IL4R polymorphisms with stevens-johnson syndrome. The Journal of Allergy and Clinical Immunology 2007, 120:1457-1459.
97. Ueta M., Sotozono C., Inatomi T., Kojima K., Tashiro K., Hamuro J., Kinoshita S. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. The British Journal of Ophthalmology 2007, 91:962-965.
98. Ueta M., Sotozono C., Tokunaga K., Yabe T., Kinoshita S. Strong association between HLA-A*0206 and stevens-johnson syndrome in the Japanese. American Journal of Ophthalmology 2007, 143:367-368.
99. Ueta M., Hamuro J., Ueda E., Katoh N., Yamamoto M., Takeda K., Akira S., Kinoshita S. Stat6-independent tissue inflammation occurs selectively on the ocular surface and perioral skin of IkappaBzeta-/- mice. Investigative Ophthalmology & Visual Science 2008, 49:3387-3394.
100. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., Kinoshita S. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Investigative Ophthalmology & Visual Science 2008, 49:1809-1813.
101. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., Kinoshita S. Association of Fas ligand gene polymorphism with stevens-johnson syndrome. The British Journal of Ophthalmology 2008, 92:989-991.
102. Ueta M., Tokunaga K., Sotozono C., Inatomi T., Yabe T., Matsushita M., Mitsuishi Y., Kinoshita S. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Molecular Vision 2008, 14:550-555.
103. Ueta M., Matsuoka T., Narumiya S., Kinoshita S. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. The Journal of Allergy and Clinical Immunology 2009, 123:466-471.
104. Ueta M., Sotozono C., Takahashi J., Kojima K., Kinoshita S. Examination of Staphylococcus aureus on the ocular surface of patients with catarrhal ulcers. Cornea 2009, 28:780-782.
105. Ueta M., Uematsu S., Akira S., Kinoshita S. Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. The Journal of Allergy and Clinical Immunology 2009, 123:1187-1189.
106. Ueta M., Hamuro J., Kinoshita S. Spatio-temporal dual effects of IkappaBzeta dictates the caution on visual disturbance resulting from IkappaBzeta deficiency. Immunology Letters 2010, 133:115.
107. Ueta M., Mizushima K., Yokoi N., Naito Y., Kinoshita S. Gene-expression analysis of polyI: C-stimulated primary human conjunctival epithelial cells. The British Journal of Ophthalmology 2010, 94:1528-1532.
108. Ueta M., Sotozono C., Nakano M., Taniguchi T., Yagi T., Tokuda Y., Fuwa M., Inatomi T., Yokoi N., Tashiro K., Kinoshita S. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. The Journal of Allergy and Clinical Immunology 2010, 126:1218-1225. e1210.
109. Ueta M., Kawai T., Yokoi N., Akira S., Kinoshita S. Contribution of IPS-1 to polyI: C-induced cytokine production in conjunctival epithelial cells. Biochemical and Biophysical Research Communications 2011, 404:419-423.
110. Ueta M., Matsuoka T., Yokoi N., Kinoshita S. Prostaglandin E2 suppresses polyinosine-polycytidylic acid (polyI: C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells. The British Journal of Ophthalmology 2011, 95:859-863.
111. Ueta M., Matsuoka T., Yokoi N., Kinoshita S. Prostaglandin E receptor subtype EP3 downregulates TSLP expression in human conjunctival epithelium. The British Journal of Ophthalmology 2011, 95:742-743.
112. Ueta M., Sotozono C., Yokoi N., Inatomi T., Kinoshita S. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders. PloS One 2011, 6:e25209.
113. Ueta M., Sotozono C., Yokoi N., Kinoshita S. Downregulation of monocyte chemoattractant protein 1 expression by prostaglandin E(2) in human ocular surface epithelium. Archives of Ophthalmology 2012, 130:249-251.
114. Ueta M., Tamiya G., Tokunaga K., Sotozono C., Ueki M., Sawai H., Inatomi T., Matsuoka T., Akira S., Narumiya S., Tashiro K., Kinoshita S. Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes. The Journal of Allergy and Clinical Immunology 2012, 129:1413-1416.
115. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annual Review of Pharmacology and Toxicology 1998, 38:97-120.
116. Wolf R., Orion E., Marcos B., Matz H. Life-threatening acute adverse cutaneous drug reactions. Clinics in Dermatology 2005, 23:171-181.
117. Xu Y., Johansson M., Karlsson A. Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria. The Journal of Biological Chemistry 2008, 283:1563-1571.
118. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto N., Yamamoto S., Muta T., Takeda K., Akira S. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004, 430:218-222.
119. Yamane Y., Aihara M., Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergology International 2007, 56:419-425.
120. Yamazaki S., Muta T., Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. The Journal of Biological Chemistry 2001, 276:27657-27662.
121. Yetiv J.Z., Bianchine J.R., Owen J.A. Etiologic factors of the stevens-johnson syndrome. Southern Medical Journal 1980, 73:599-602.
122. Ying S., O'Connor B., Ratoff J., Meng Q., Mallett K., Cousins D., Robinson D., Zhang G., Zhao J., Lee T.H., Corrigan C. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. The Journal of Immunology 2005, 174:8183-8190.
123. Ying S., O'Connor B., Ratoff J., Meng Q., Fang C., Cousins D., Zhang G., Gu S., Gao Z., Shamji B., Edwards M.J., Lee T.H., Corrigan C.J. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. The Journal of Immunology 2008, 181:2790-2798.
124. Zhang J., Xu K., Ambati B., Yu F.S. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Investigative ophthalmology & visual science 2003, 44:4247-4254.
125. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303:1522-1526.
126. Zhang J., Kumar A., Wheater M., Yu F.S. Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness. Immunology and Cell Biology 2008, 87:141-148.
127. Ziegler S.F., Liu Y.J. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nature Immunology 2006, 7:709-714.